Demand Forecasting for Controlled Substances

On August 27, 2025, the Reagan-Udall Foundation for the FDA, in collaboration with the Food and Drug Administration (FDA), hosted a hybrid public meeting on "Demand Forecasting for Controlled Substances.” This meeting includeed exploration of the complex factors that are considered when estimating the medical, scientific, and reserve stock needs for Schedule I and Schedule II substances, such as opioids and stimulants. Speakers included representatives from government agencies, the private sector, and academic researchers. (0:00) Welcome (5:30) FDA Opening Remarks (11:58) CDER Fireside Chat (22:51) Overview (37:51) Public Comment (1:53:06) Demand Forecasting Panel